Rahul Pal, Murali Krishnamoorthy, Aya Matsui, Homan Kang, Satoru Morita, Hajime Taniguchi, Tatsuya Kobayashi, Atsuyo Morita, Hak Soo Choi, Dan G. Duda, et al. Fluorescence Lifetime Imaging Enables In vivo Quantification of PD-L1 Expression and Inter-tumoral Heterogeneity. Cancer Research. 2024
Satoru Morita, Pin-Ji Lei, Kohei Shigeta, Tomofumi Ando, Tatsuya Kobayashi, Hiroto Kikuchi, Aya Matsui, Peigen Huang, Mikael J. Pittet, Dan G. Duda. Combination CXCR4 and PD1 blockade enhances intratumoral dendritic cell activation and immune responses against hepatocellular carcinoma. Cancer Immunology Research. 2024
Bocheng Wu, Subhasish Tapadar, Zhiping Ruan, Carrie Sun, Rebecca Arnold, Alexis Johnston, Jeremiah Olugbami, Uche Arunsi, David Gaul, John Petros, et al. A Novel Liver Cancer-Selective Histone Deacetylase Inhibitor Is Effective Against Hepatocellular Carcinoma and Induces Durable Responses with Immunotherapy. bioRxiv : the preprint server for biology. 2024
Rahul Pal, Murali K, Aya Matsui, Homan Kang, Satoru Morita, Hajime Taniguchi, Tatsuya Kobayashi, Atsuyo Morita, Hak Soo Choi, Dan G Duda, et al. In vivo quantification of programmed death-ligand-1 expression heterogeneity in tumors using fluorescence lifetime imaging. Research square. 2023
Satoru Morita, Hiroto Kikuchi, Grace Birch, Aya Matsui, Atsuyo Morita, Tatsuya Kobayashi, Zhiping Ruan, Peigen Huang, Alexei Hernandez, Erin M Coyne, et al. Preventing NK cell activation in the damaged liver induced by cabozantinib/PD-1 blockade increases survival in hepatocellular carcinoma models. bioRxiv : the preprint server for biology. 2023
2022/01 - 2024/08 Massachusetts General Hospital, Harvard Medical School Department of Radiation Oncology, Edwin L. Steele Laboratories Research Fellow